Skip to content

Effect of Jiaji point injection of PRP combined with drugs on postherpetic neuralgia

Effect of Jiaji point injection of PRP combined with drugs on postherpetic neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056061
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-03-01
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Sponsors

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients who still had pain 3 months after the herpes zoster lesions subsided and were excluded from pain caused by other diseases; 2.The age range is above 50 years old; 3.No serious systemic diseases, stable vital signs, no bleeding tendency; 4.Willing to receive PRP treatment; 5.No treatment was taken for PHN within 1 week; 6.Can read and understand by themselves, and can complete self-evaluation.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Suffering from special types of herpes zoster, such as eyes, ears, viscera, meningeal herpes zoster lesions outside the body; 3.Do not take pain as the main symptom; 4.Patients who have used corticosteroids or immunosuppressants within one month and have a history of drug abuse; 5.Allergic constitution, or scar constitution, or infectious skin disease patients in the past.

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale (NRS);

Secondary

MeasureTime frame
Postherpetic Neuralgia Quality of Life Scale (PHNQOLS);Pittsburgh Sleep Quality Index;Hamilton Depression Scale score;

Countries

China

Contacts

Public ContactZhang zhongzhao

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

zhangzz818@163.com+86 15286090061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026